Hepatocellular carcinoma (HCC) is the most common form of liver cancer; most cases of HCC (approximately 80%) are associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Variations in the age-, sex-, et al. race-specific rates of HCC rates in different geographic regions are likely to be related to differences in the prevalence of hepatitis viruses in the populations, as well as the timing of the spread of the viral infection et al. the age of individuals at the time of the infection. According to the International Agency for Research on Cancer, liver cancer is the fifth most common cancer in men worldwide (523,000 cases per year,7.9% of all cancers) et al. the seventh in women (226,000 cases per year, 6.5% of all cancers). Liver cancer has high mortality; the geographic distribution of mortality is similar to that of incidence. Most of the burden of liver cancer is in developing countries, where almost 85% of the cases occur (El-Serag, 2012) .
INTRODUCTION
Hepatocellular carcinoma (HCC) is the most common form of liver cancer; most cases of HCC (approximately 80%) are associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Variations in the age-, sex-, et al. race-specific rates of HCC rates in different geographic regions are likely to be related to differences in the prevalence of hepatitis viruses in the populations, as well as the timing of the spread of the viral infection et al. the age of individuals at the time of the infection. According to the International Agency for Research on Cancer, liver cancer is the fifth most common cancer in men worldwide (523,000 cases per year,7.9% of all cancers) et al. the seventh in women (226,000 cases per year, 6.5% of all cancers). Liver cancer has high mortality; the geographic distribution of mortality is similar to that of incidence. Most of the burden of liver cancer is in developing countries, where almost 85% of the cases occur (El-Serag, 2012) .
The burden of HCC has been increasing in Egypt with a doubling in the incidence rate in the past 10 years. This has been attributed to several biological (e.g. HBV et al. HCV infections) et al. environmental factors (e.g. aflatoxin) .
ARTICLE INFO
This study investigates the antiproliferative effect of hesperidin on human hepatocarcinoma HepG2 cell line. Different concentrations of hesperidin 25, 50 et al. 100 µM were used for different time intervals 24, 48 et al. 72 hrs, while untreated cells were served as control. The effects of different concentrations of hesperidin on HepG2 cell viability, nuclear factor kappa-B (NFkB) gene expression et al. alpha-fetoprotein (AFP) secretion from the cells were measured. The results of the cell viability assays showed that hesperidin concentrations exhibited a highly significant inhibition effect on HepG2 cell proliferation which was evidenced by reduction in viable cells count. The results were confirmed by microscopical observations of cell morphology. Furthermore, hesperidin suppressed the activity of NF-kB gene expression of HepG2 cells compared to the control. Also it caused a highly significant depression in the level of AFP in HepG2 cells compared with that of controls in time dependent manner. Therefore, the conclusion was that hesperidin inhibits the growth of HepG2 cells through suppressing the activity of NF-kB gene expression et al. modulates the biochemical marker AFP.
Other factors such as cigarette smoking, occupational exposure to chemicals as pesticides, et al. endemic infections in the community, such as schistosomiasis, may have additional roles in the etiology or progression of the disease (Anwar, et al., 2008) . Although substantial advances have been made in HCC chemotherapy regimens, the efficacy of anti-cancer drugs is often limited by adverse side effects. Accordingly, new approaches are needed to further the development of an effective therapy against HCC. So, focus has shifted to materials from natural sources that aid in treating cancer progress et al. metastasis, while minimizing adverse side effects (Chun, et al., 2011) .
Hesperidin, a flavanone glycoside found abundantly in citrus fruits, possesses a wide range of pharmacological properties including potential anti-inflammatory et al. anticancer effects (Ou, 2002; BenaventeGarcia & Castillo, 2008 (Garg et al., 2001; Knekt et al., 2002; Choi, 2007; Akiyama et al., 2010; Ghorbani et al.., 2012; Kamaraj et al., 2011; Lee et al., 2011) . In addition, hesperidin as a radioprotective et al. chemoprotective therapeutic agent is expected to prevent invasion or metastasis of human cancers (Lee et al., 2010) . Anti-cancer effects of hesperidin was studied in tumor implanted animal models or culture cell lines of several cancer types, including colon cancer, bladder cancer, hepatocarcinoma cancer, et al. breast cancer, but the mechanism of this compound was not understood (Park et al., 2008; Choi, 2007; Lee et al., 2010; Tanaka et al., 1997; Yang et al., 1997; Yeh et al., 2009 
Real-Time PCR (RT-PCR) amplification of NF-kB
HepG2 cells were cultured et al. treated as described above. The cell pellets were collected after being trypsinized et al. centrifuged. Total RNA was extracted using the RNeasy mini kit (Qiagen, USA). Total RNA was transcribed into c-DNA using the reverse transcription system kit high capacity RNA-to-cDNA master mix (Applied Biosystems, USA) according to the manufacturer's instructions. The resultant cDNA was diluted 10 times in double distilled water et al. kept at -20 °C for RT-PCR analysis. Then diluted cDNAs were amplified with the following primer pairs, mouse ß-actin was amplified as the control, using quantifast SYBR Green PCR kit (Qiagen, USA) in a 10 µl final volume according to the manufacturer's instructions: 
Assay of AFP synthesis
After treatment of 1×10 
Data Analysis
The statistical analysis of the data was carried out using ANOVA followed by Tukey's test. Values are expressed as mean ( ) ± stet al.ard deviation (SD): -Insignificant difference from corresponding control (P>0.05). -Significant difference from corresponding control (P<0.05).
-Highly significant difference from corresponding control (P<0.001).
RESULTS

Hesperidin inhibited the proliferation of HepG2cells
Cell viability assay was done to determine the effect of hesperidin on HepG2 growth rate, this study shown that hesperidin significantly inhibits HepG2 cell growth et al. its effects were proportional with increasing the concentration et al. the time of exposure (Fig. 1 ). Microscopic observations of cell morphology show that hesperidin induced morphological changes in HepG2 cells towards more mature forms of hepatocytes using an inverted light microscope (Fig. 2) .
Hesperidin inhibited the activity of nuclear factor kappa B gene expression of HepG2 cells. The study showed a time dependent inhibition in the activity of NF-kB gene expression of HepG2 cells treated with 25, 50 et al. 100 µM of hesperidin which was evident by depression in the fold change of NF-kB compared with the control (Fig. 3) .
Hesperidin inhibited AFP secretion in HepG2 cells culture medium
The AFP level in the culture medium of hesperidin-treated groups was significantly lower than that of the control group at different time intervals. 25µM hesperidin concentration inhibited AFP secretion by 23.8, 31.9 et al. 35 (Chiba et al., 2003) . Hesperidin has been reported to inhibit cell cycle progression in human pancreatic cells (Patil et al., 2009) . It also reduces the generation of reactive oxygen species et al. triggers caspase-dependent apoptosis in human polymorphonuclear neutrophils in vitro (Zielinska-Przyjemska et al. Ignatowicz, 2008) .
DISCUSSION
It has been shown that hesperidin possesses cancer chemopreventive effect on some tumor cells. Its lack of toxicity makes it apotentially attractive agent for use in conjunction with chemotherapy (Aranganathan & Nalini, 2009). Hesperidin has dose-dependent cytotoxic effects on human colon cancer cells, accompanied by DNA fragmentation caspase-3 activation (Park et al., 2008) . However, in spite of many years of research et al. speculation, the exact mechanisms underlying hesperidininduced apoptosis have not been clearly understood (Nazari et al., 2011) .
HCC is one of the most common malignancies worldwide. Despite many therapeutic approaches, the long-term prognosis of HCC is poor because of higher relapse et al. intrahepatic metastasis. Tumor cells to evadeprogrammed cell death are a major characteristic that enables their uncontrolled growth (Jeong et al., 2010) .
HCC (park et al., 2012) . Recent studies have shown that inactivation of the NF-kB in the hepatic compartment inhibits liver tumor formation through induction of cell death et al. inhibition of compensatory proliferation. Furthermore, mounting evidence has illustrated a major role of NF-kB in inducible chemo-resistance of HCCs (Wang et al., 2007) .
RT-PCR analysis showed that hesperidin suppressed the constitutive activity of NF-kB gene expression of HepG2 cells with treatment of hesperidin which effectively induced tumor growth when compared to the control.
This result was in agreement with Lee et al., (2010) (Li et al., 2011) . Hepatoma cells can synthesize various tumor-related proteins, such as AFP (Yao et al., 2007) . Specifically, AFP, which is synthesized by transformed hepatocytes with high-grade malignancy, is known to be present in HepG2 cells (Cid et al., 2012) .
As regard to AFP results in present study, showed a highly significant depression (P<0.001) in the levels of AFP in HepG2 cells treated with 25, 50 et al. 100 µM respectively compared with that of controls. Also these results showed that 100 µM concentration of hesperidin induced higher activity than other concentrations.
The content of AFP in the supernatant of cultured HepG2 cells when significantly reduced indicated that, it may be a result of growth inhibition et al. apoptosis of the HepG2 cells (Liu et al., 2004) .
In conclusion, the present study demonstrates the effects of hesperidin on the proliferation of human hepatocellular carcinoma cells. It shows that hesperidin inhibit the growth of HepG2 cells through suppressing the activity of NF-kB gene expression et al. modulates the biochemical marker AFP. 
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